Vanguard Group’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $440K | Sell |
|
|||||
|
2025
Q1 | $353K | Sell |
|
|||||
|
2024
Q4 | $333K | Hold |
|
|||||
|
2024
Q3 | $643K | Hold |
|
|||||
|
2024
Q2 | $624K | Hold |
|
|||||
|
2024
Q1 | $888K | Hold |
|
|||||
|
2023
Q4 | $872K | Buy |
|
|||||
|
2023
Q3 | $1.16M | Hold |
|
|||||
|
2023
Q2 | $1.59M | Hold |
|
|||||
|
2023
Q1 | $1.44M | Hold |
|
|||||
|
2022
Q4 | $2.15M | Buy |
|
|||||
|
2022
Q3 | $1.73M | Sell |
|
|||||
|
2022
Q2 | $3.64M | Buy |
|
|||||
|
2022
Q1 | $6.63M | Sell |
|
|||||
|
2021
Q4 | $7.16M | Buy |
|
|||||
|
2021
Q3 | $14M | Buy |
|
|||||
|
2021
Q2 | $22.1M | Buy |
|
|||||
|
2021
Q1 | $24.2M | Buy |
|
|||||
|
2020
Q4 | $15.9M | Buy |
|
|||||
|
2020
Q3 | $20.2M | Buy |
|
|||||
|
2020
Q2 | $15.7M | Sell |
|
|||||
|
2020
Q1 | $18M | Buy |
|
|||||
|
2019
Q4 | $40.2M | Buy |
|
|||||
|
2019
Q3 | $53.1M | Buy |
|
|||||
|
2019
Q2 | $37.9M | Buy |
|
|||||
|
2019
Q1 | $67.1M | Buy |
|
|||||
|
2018
Q4 | $50.7M | Buy |
|
|||||
|
2018
Q3 | $84.6M | Buy |
|
|||||
|
2018
Q2 | $73.3M | Buy |
|
|||||
|
2018
Q1 | $55.5M | Sell |
|
|||||
|
2017
Q4 | $68.9M | Buy |
|
|||||
|
2017
Q3 | $57.7M | Buy |
|
|||||
|
2017
Q2 | $53.9M | Buy |
|
|||||
|
2017
Q1 | $70.6M | Buy |
|
|||||
|
2016
Q4 | $53.6M | Buy |
|
|||||
|
2016
Q3 | $61.8M | Buy |
|
|||||
|
2016
Q2 | $74.4M | Buy |
|
|||||
|
2016
Q1 | $36.8M | Buy |
|
|||||
|
2015
Q4 | $52.7M | Buy |
|
|||||
|
2015
Q3 | $28M | Buy |
|
|||||
|
2015
Q2 | $31.3M | Buy |
|
|||||
|
2015
Q1 | $23M | Buy |
|
|||||
|
2014
Q4 | $14.9M | Buy |
|
|||||
|
2014
Q3 | $14.3M | Buy |
|
|||||
|
2014
Q2 | $12.4M | Buy |
|
|||||
|
2014
Q1 | $16.8M | Buy |
|
|||||
|
2013
Q4 | $10.5M | Buy |
|
|||||
|
2013
Q3 | $3.3M | Buy |
|
|||||
|
2013
Q2 | $3.18M | Buy |
|